Orchid Chemicals oral formulations plant receives USFDA nodOrchid's Oral Formulations facility at Irungattukottai near Chennai was successfully inspected. Orchid Chemicals & Pharmaceuticals Ltd has announced that Orchid's Oral Formulations facility at Irungattukottai near Chennai was successfully inspected ... India Infoline, 1 day ago |
7 images for orchid chemicals and pharmaceuticals ltd | ||||
Orchid Pharma gets NOC to complete $200 mn sale with HospiraChennai-based Orchid Chemicals and Pharmaceuticals Ltd has received all the no objection certificates (NOCs) from the lenders to complete its $200 million (around Rs 1,135 crore as per the current currency rate) deal with US-based Hospira Inc, said ... Business Standard, 1 week ago
Orchid Chemicals receives NOC to complete $200 mn sale: reports
India Infoline, 1 week ago
|
Orchid Chemicals & Pharmaceuticals Ltd: Company Profile - New SWOT ReportThis comprehensive SWOT profile of Orchid Chemicals & Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the ... TransWorldNews, 1 month ago
Orchid Chem out-licenses molecule to German firm
DNA India, 2 months ago
BRIEF: Orchid collaborates with Allecra for anti-bacterial research
Individual.com, 2 months ago
Orchid enters into strategic partnership with Allecra Therapeutics
Moneycontrol.com, 2 months ago
|
Orchid Chemicals in red, net loss at Rs. 132 cr in Q4Orchid Chemicals and Pharmaceuticals, a Rs.1,200 crore plus Chennai based pharma giant, has suffered heavy setback during the fourth quarter ended in March 2013 on account of heavy interest burden and lower sales. Its net loss for the fourth quarter ... PharmaBiz, 1 month ago
Orchid Chemicals posts Rs 132 crore net loss in Q4
Business Standard, 1 month ago
|
Orchid Chemicals clear USFDA inspectionOrchid Chemicals Pharmaceuticals Ltd has informed BSE that Orchid's Cephalosporin API manufacturing complex located in Alathur, Chennai has successfully cleared the USFDA inspection that it went through. Money Control, 2 months ago
Orchid Chemicals & Pharmaceuticals' Alathur Unit clears USFDA inspection
Equity Bulls, 2 months ago
Orchid Chemicals gains as Alathur unit clears FDA inspection
Smart Investor, 2 months ago
|
Orchid transfers intellectual property to European firmCity-based Orchid Chemicals and Pharmaceuticals Ltd. has transferred the intellectual property (IP) related to an antibiotic discovery programme to Europe-based Allecra Therapeutics, a top company official said Thursday."We have completed the in-house animal ... Prokerala, 2 months ago
National Intellectual Property Awards 2013 Announced in India
Intellectual Property News Agency, 1 month ago
|
Forbion Capital Partners co-leads €15 Million Series A Financing for Allecra TherapeuticsFinancing for development of novel antibiotic treatments in partnership with Orchid Chemicals & Pharmaceuticals Ltd. Munich, Germany and Naarden, The Netherlands, 18 April 2013 Forbion Capital Partners, the Dutch life sciences venture capital firm, ... FierceBiotech, 2 months ago
Edmond de Rothschild Investment Partners co-leads the €15 Million Series A financing of Allecra Therapeutics with its new fund BioDiscovery 4
OSIX News, 2 months ago
|
Stock Prices as on June 18, 2013Data for 800 companies from Bombay Stock Exchange. Values are: days closing price, previous closing price in brackets, 52-week low and high in bold, and volume traded (in 000) in brackets. GROUP A A A B B 614.95(614.65) 830-469 (38) A C C 1213.15(1206.6) ... Deccan Herald, 1 day ago
Stock Prices as on May 14, 2013
Deccan Herald, 1 month ago
Stock Prices as on May 13, 2013
Deccan Herald, 1 month ago
Stock prices as on May 7, 2013
Deccan Herald, 1 month ago
|
News Roundup: Curatio Health in talks with two Tata Capital PE funds to raise $52MThe transaction, if successful, will also provide an exit to Fulcrum Ventures, which co-invested Rs 8.5 crore in the company, along with investor GK Ramani in 2005. Curatio Healthcare has entered into preliminary talks with two private equity ... VC Circle, 1 day ago
|
Type 2 Diabetes Pipeline Review, H1 2013Publisher: Global Markets Direct × Global Markets Direct Global Markets Direct Close View all Global Markets Direct Products Pages: 432 Format: PDF Product Line: Pipeline Review Type: Report Product Code: GMDHC3226IDB 1943 € ... PipelineReview, 2 days ago
Research and Markets Adds Report: Global Medication Management System Market 2012-2016
Individual.com, 2 weeks ago
Global Medication Management System Market 2012-2016 with Baxter International Inc., CareFusion Inc. and Hospira Inc. Dominating
TradingCharts.com, 3 weeks ago
Research and Markets: Global Medication Management System Market 2012-2016 with Baxter International Inc., CareFusion Inc. and Hospira Inc. Dominating
TMC Net, 3 weeks ago
More from: , Research and Markets...and 4 other sources
|